Literature DB >> 21802312

Relationship of plasma leptin and adiponectin concentrations with menopausal status in Tunisian women.

Samir Ben Ali1, Riadh Jemaa, Bouchra Ftouhi, Amani Kallel, Moncef Feki, Hedia Slimene, Naziha Kaabachi.   

Abstract

To evaluate the effect of menopausal status and body mass index (BMI) on circulating leptin and adiponectin concentrations and investigate whether there is an influence of menopausal transition on the relationships of these adipokines and leptin to adiponectin (L/A) ratio with lipid profile and insulin resistance in a sample of Tunisian women. One hundred ninety-six premenopausal (mean age 35.3±7.6 years) and 180 postmenopausal women (mean age 53.4±6.2 years) were included in the study. Participants were stratified into obese and normal weight groups based upon their baseline BMI. Fasting glucose, HDL-cholesterol (HDL-C), triglycerides (TG), total cholesterol (TC), insulin, leptin, and adiponectin concentrations were measured. Homeostasis model assessment of insulin resistance (HOMA-IR) was calculated. Premenopausal women had significantly higher leptin and L/A ratio and lower adiponectin levels than postmenopausal women. Menopause had no effect on the mean values of BMI, insulin or HOMA-IR, HDL-C, and TG. Using a multiple linear regression model, menopausal status was identified, as significant independent predictor for leptin and adiponectin levels. Irrespective of the menopausal status, obese women exhibited higher leptin and L/A ratio and lower adiponectin levels compared to those with normal weight. Comparison between the two menopausal stages in obese and normal weight groups showed that leptin and L/A ratio decreased, while adiponectin increased from pre- to postmenopausal stage only in obese group. The L/A ratio correlated better with lipid profile and HOMA-IR in postmenopausal stage. The present study showed a significant interaction between menopause and BMI on leptin and adiponectin secretion. Menopausal transition affects the relationships of these adipokines with lipids and insulin resistance.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21802312     DOI: 10.1016/j.cyto.2011.06.026

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  8 in total

1.  Dysfunctional Eating Behaviour and Leptin in Middle-Aged Women: Role of Menopause and a History of Anorexia Nervosa.

Authors:  Suzana Stojiljkovic-Drobnjak; Susanne Fischer; Myrtha Arnold; Wolfgang Langhans; Ulrike Kuebler; Ulrike Ehlert
Journal:  Int J Behav Med       Date:  2021-03-15

2.  Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study.

Authors:  Amy L Gross; Craig J Newschaffer; Judith Hoffman-Bolton; Nader Rifai; Kala Visvanathan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-05-07       Impact factor: 4.254

3.  Adiponectin and metabolic syndrome in a Tunisian population.

Authors:  Samir Ben Ali; Riadh Jemaa; Bouchra Ftouhi; Amani Kallel; Moncef Feki; Hedia Slimene; Naziha Kaabachi
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

4.  Similar and additive effects of ovariectomy and diabetes on insulin resistance and lipid metabolism.

Authors:  Shady H Tawfik; Bothaina F Mahmoud; Mohamed I Saad; Mona Shehata; Maher A Kamel; Madiha H Helmy
Journal:  Biochem Res Int       Date:  2015-03-05

5.  Menopause Analytical Hormonal Correlate Outcome Study (MAHCOS) and the association to brain electrophysiology (P300) in a clinical setting.

Authors:  Eric R Braverman; David Han; Marlene Oscar-Berman; Tatiana Karikh; Courtney Truesdell; Kristina Dushaj; Florian Kreuk; Mona Li; Danielle Stratton; Kenneth Blum
Journal:  PLoS One       Date:  2014-09-24       Impact factor: 3.240

6.  The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study.

Authors:  Laura Rotundo; Alana Persaud; Mirela Feurdean; Sushil Ahlawat; Hyun-Seok Kim
Journal:  Clin Mol Hepatol       Date:  2018-08-02

7.  Symptomatic menopausal transition and risk of subsequent stroke.

Authors:  Chao-Hung Yu; Chew-Teng Kor; Shuo-Chun Weng; Chia-Chu Chang; Ching-Pei Chen; Chia-Lin Wu
Journal:  PeerJ       Date:  2019-10-30       Impact factor: 2.984

Review 8.  A review of menopause nomenclature.

Authors:  Ananthan Ambikairajah; Erin Walsh; Nicolas Cherbuin
Journal:  Reprod Health       Date:  2022-01-31       Impact factor: 3.223

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.